Contego Medical
Contego Medical, LLC, based in Raleigh, US, develops integrated angioplasty and embolic protection devices for cardiovascular treatment.
Founded
2005Contego Medical, LLC, based in Raleigh, US, develops integrated angioplasty and embolic protection devices for cardiovascular treatment.
Founded in Raleigh, North Carolina, Contego Medical, LLC focuses on developing advanced medical devices that integrate angioplasty and embolic protection into a single platform for the treatment of cardiovascular diseases. Their core mission is to enhance patient outcomes through innovative and simplified solutions. The company's product lineup includes the Carotid Paladin IEP, Neuroguard IEP, Excipio Thrombectomy, and Vanguard IEP, targeting various aspects of cardiovascular health, particularly in carotid and peripheral vascular applications.
Contego Medical has garnered attention for its cutting-edge technology and has attracted notable investors and industry leaders. The leadership team comprises experienced professionals dedicated to advancing cardiovascular treatment. The company has achieved significant milestones, including successful clinical trials and regulatory approvals, which have positioned it as a key player in the medical device industry. Through its innovative products, Contego Medical continues to make a substantial impact on improving cardiovascular care and patient outcomes worldwide.
Companies similar to Contego Medical include East End Medical, Transverse Medical, Concept Medical and Emboline.
Contego Medical was founded in 2005.
Contego Medical's headquarters is located in Raleigh, NC, US.
Contego Medical's most recent funding round was for $23M (USD) in April 2023.
As of Apr 19, 2023, Contego Medical has disclosed funding of $65.8M (USD). Undisclosed round amounts are excluded.
Contego Medical has 40 employees as of Feb 5, 2024.
